M-M-RVaxPro
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M-M-RVaxPro, covering 2025-10-30 to 2025-10-30. Get the full timeline:
Most recent: EMA Authorised: M-M-RVaxPro (measles virus Enders’ Edmonston strain (live, attenuated);mumps virus Jeryl Lynn (level B) strain (live, attenuated);rubella virus Wistar RA 27/3 strain (live, attenuated)) — Merck Sharp & Dohme B.V.